Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years
ConclusionBased on our analysis of publications over the past two decades, there are currently frequent challenges related to various aspects of informed consent in cancer clinical drug trials in China. Furthermore, only a limited number of high-quality research studies on informed consent in cancer clinical drug trials in China are available to date. Efforts toward improvement of informed consent practice, in the form of guidelines or further regulations in China, should draw on both experience from other countries and high-quality local evidence. (Source: Trials)
Source: Trials - July 7, 2023 Category: Research Source Type: clinical trials

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Condition:   Major Depressive Disorder Interventions:   Drug: Vortioxetine Tablet;   Drug: SSRI Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions:   Telangiectasia, Hereditary Hemorrhagic;   Intracranial Arteriovenous Malformations Intervention:   Other: Brain MRI Sponsor:   Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database
Conditions:   Cancer;   Immune-related Adverse Event;   Immune Checkpoint Inhibitor-Related Myocarditis Intervention:   Drug: Immune checkpoint inhibitor Sponsors:   Groupe Hospitalier Pitie-Salpetriere;   Institut Curie Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions:   Telangiectasia, Hereditary Hemorrhagic;   Intracranial Arteriovenous Malformations Intervention:   Other: Brain MRI Sponsor:   Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Condition:   Major Depressive Disorder Interventions:   Drug: Vortioxetine Tablet;   Drug: SSRI Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions:   Telangiectasia, Hereditary Hemorrhagic;   Intracranial Arteriovenous Malformations Intervention:   Other: Brain MRI Sponsor:   Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database
Conditions:   Cancer;   Immune-related Adverse Event;   Immune Checkpoint Inhibitor-Related Myocarditis Intervention:   Drug: Immune checkpoint inhibitor Sponsors:   Groupe Hospitalier Pitie-Salpetriere;   Institut Curie Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions:   Telangiectasia, Hereditary Hemorrhagic;   Intracranial Arteriovenous Malformations Intervention:   Other: Brain MRI Sponsor:   Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Condition:   Major Depressive Disorder Interventions:   Drug: Vortioxetine Tablet;   Drug: SSRI Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials